Cargando…

Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease

BACKGROUND: Several non-motor features of Parkinson’s disease (PD) are known to adversely affect patient health-related quality of life (HRQL). However, the specific impact of neuropsychiatric complications, such as impulsive behaviour, is yet to be elucidated. OBJECTIVES: The present cross-sectiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyadevan, Ashani, Bakeberg, Megan, Byrnes, Michelle, Kenna, Jade, McGregor, Sarah, Ghosh, Soumya, Horne, Malcom K., Stell, Rick, Evans, Tess, Mastaglia, Frank L., Anderton, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063484/
https://www.ncbi.nlm.nih.gov/pubmed/36637657
http://dx.doi.org/10.1007/s11136-022-03321-w
_version_ 1785017715772096512
author Jeyadevan, Ashani
Bakeberg, Megan
Byrnes, Michelle
Kenna, Jade
McGregor, Sarah
Ghosh, Soumya
Horne, Malcom K.
Stell, Rick
Evans, Tess
Mastaglia, Frank L.
Anderton, Ryan
author_facet Jeyadevan, Ashani
Bakeberg, Megan
Byrnes, Michelle
Kenna, Jade
McGregor, Sarah
Ghosh, Soumya
Horne, Malcom K.
Stell, Rick
Evans, Tess
Mastaglia, Frank L.
Anderton, Ryan
author_sort Jeyadevan, Ashani
collection PubMed
description BACKGROUND: Several non-motor features of Parkinson’s disease (PD) are known to adversely affect patient health-related quality of life (HRQL). However, the specific impact of neuropsychiatric complications, such as impulsive behaviour, is yet to be elucidated. OBJECTIVES: The present cross-sectional, observational study aimed to investigate the effects of heightened trait impulsivity on HRQL in individuals with PD. METHODS: A total of 322 people with idiopathic PD were sequentially recruited from Movement Disorder clinics across Australia. Trait impulsivity in patients was determined by Barratt’s Impulsiveness Scale Version 11 (BIS-11), and grouped into tertiles (low, medium, and high). Patient HRQL was determined by the 39-item Parkinson’s Disease Questionnaire (PDQ-39), complemented by the Cambridge Behavioural Inventory-Revised (CBI-R) indicating caregivers’ perception of patient HRQL. RESULTS: When total BIS-11 scores were grouped into tertiles, patient perceived and caregiver-perceived HRQL were 1.7-fold (p < .001) and 2.2-fold (p < .001) worse in the high BIS-11 group when compared to patients in the low group. Univariate analysis revealed significant associations between second-order attentional (p < .001) and non-planning (p < .001) impulsivity domains with PDQ-39 scores. When controlling for confounding demographic and clinical variables, a multivariate linear regression model revealed second-order attentional impulsivity was independently predictive of poor patient perceived HRQL (p < .001). CONCLUSION: These findings suggest that increasing trait impulsivity is significantly associated with patient perceived HRQL in PD. Improved knowledge and recognition of subclinical impulsivity may guide clinicians’ treatment and reduce disease burden for patients experiencing PD symptoms.
format Online
Article
Text
id pubmed-10063484
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100634842023-04-01 Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease Jeyadevan, Ashani Bakeberg, Megan Byrnes, Michelle Kenna, Jade McGregor, Sarah Ghosh, Soumya Horne, Malcom K. Stell, Rick Evans, Tess Mastaglia, Frank L. Anderton, Ryan Qual Life Res Article BACKGROUND: Several non-motor features of Parkinson’s disease (PD) are known to adversely affect patient health-related quality of life (HRQL). However, the specific impact of neuropsychiatric complications, such as impulsive behaviour, is yet to be elucidated. OBJECTIVES: The present cross-sectional, observational study aimed to investigate the effects of heightened trait impulsivity on HRQL in individuals with PD. METHODS: A total of 322 people with idiopathic PD were sequentially recruited from Movement Disorder clinics across Australia. Trait impulsivity in patients was determined by Barratt’s Impulsiveness Scale Version 11 (BIS-11), and grouped into tertiles (low, medium, and high). Patient HRQL was determined by the 39-item Parkinson’s Disease Questionnaire (PDQ-39), complemented by the Cambridge Behavioural Inventory-Revised (CBI-R) indicating caregivers’ perception of patient HRQL. RESULTS: When total BIS-11 scores were grouped into tertiles, patient perceived and caregiver-perceived HRQL were 1.7-fold (p < .001) and 2.2-fold (p < .001) worse in the high BIS-11 group when compared to patients in the low group. Univariate analysis revealed significant associations between second-order attentional (p < .001) and non-planning (p < .001) impulsivity domains with PDQ-39 scores. When controlling for confounding demographic and clinical variables, a multivariate linear regression model revealed second-order attentional impulsivity was independently predictive of poor patient perceived HRQL (p < .001). CONCLUSION: These findings suggest that increasing trait impulsivity is significantly associated with patient perceived HRQL in PD. Improved knowledge and recognition of subclinical impulsivity may guide clinicians’ treatment and reduce disease burden for patients experiencing PD symptoms. Springer International Publishing 2023-01-13 2023 /pmc/articles/PMC10063484/ /pubmed/36637657 http://dx.doi.org/10.1007/s11136-022-03321-w Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Jeyadevan, Ashani
Bakeberg, Megan
Byrnes, Michelle
Kenna, Jade
McGregor, Sarah
Ghosh, Soumya
Horne, Malcom K.
Stell, Rick
Evans, Tess
Mastaglia, Frank L.
Anderton, Ryan
Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
title Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
title_full Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
title_fullStr Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
title_full_unstemmed Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
title_short Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
title_sort quality of life implications for elevated trait impulsivity in people with parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063484/
https://www.ncbi.nlm.nih.gov/pubmed/36637657
http://dx.doi.org/10.1007/s11136-022-03321-w
work_keys_str_mv AT jeyadevanashani qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT bakebergmegan qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT byrnesmichelle qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT kennajade qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT mcgregorsarah qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT ghoshsoumya qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT hornemalcomk qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT stellrick qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT evanstess qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT mastagliafrankl qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease
AT andertonryan qualityoflifeimplicationsforelevatedtraitimpulsivityinpeoplewithparkinsonsdisease